Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Naseem Amin Insider Profile
4 Followers
Naseem Amin, Senior Officer at Smith & Nephew, holds 183.00K shares in Arix Bioscience (Ticker: GB:ARIX), holds 876.00 shares in Smith & Nephew (Ticker: GB:SN). Most recently, Naseem Amin Bought ― shares of Arix Bioscience on Dec 21, 2020 for an estimated value of 376.98K.
Naseem Amin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Senior Officer
Roles that Naseem Amin holds in companies
Most Profitable Insider Trade
Stock:
Arix Bioscience
(ARIX)
(ARIX)
Rating:Informative Buy
Date:Dec 21, 2020 - Dec 21, 2021
Return:-39.60%
The most profitable trade made by Naseem Amin
Naseem Amin's Trading History
Smith & Nephew
Mar 25, 2011
Senior Officer
Uninformative Buy
―
£8.74K
Arix Bioscience
Dec 21, 2020
―
Informative Buy
376.98K
£259.86K
List of latest transactions for each holding click on a transaction to see Naseem Amin's performance on stock
You May Also Like
Naseem Amin insider profile FAQ
What is the percentage of profitable transactions made by Naseem Amin?
The percentage of profitable transactions made by Naseem Amin is ―.
What is the average return per transaction made by Naseem Amin?
The average return per transaction made by Naseem Amin is ―.
What stocks does Naseem Amin hold?
Naseem Amin holds: GB:SN, GB:ARIX stocks.
What was Naseem Amin’s latest transaction?
Naseem Amin latest transaction was an Informative Buy of 376.98K.
What was Naseem Amin's most profitable transaction?
Naseem Amin’s most profitable transaction was an Informative Buy of GB:ARIX stock on December 21, 2020. The return on the trade was -39.60%.
What is Naseem Amin's role in Smith & Nephew?
Naseem Amin's role in Smith & Nephew is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.